Yongguo Li

This inventor holds 10 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Hua Medicine (Shanghai) Ltd., Guangzhou Joyo Pharmatech Co., Ltd, Shanghai Jia Tan Pharmatech Co., Ltd.. Active years: 2012-2026.

USPTO Granted Patents = 10 (Patent Applications = 9)

% Patents Active = 70.0

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 15)

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

7 out of 13

Hua Medicine (Shanghai) Ltd.

patents

2 out of 3

Guangzhou Joyo Pharmatech Co., Ltd

patents

2 out of 2

Shanghai Jia Tan Pharmatech Co., Ltd.

patents

4. 1 out of 5,020

Hoffmann-La Roche Inc.

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12661357 - Use of pyrido[1,2-a]pyrimidone analogue (2026-06-23),

2. 12622912 - Application of pyrido[1,2-a]pyrimidinone analog (2026-05-12),

3. 12318366 - Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof (2025-06-03),

4. 12064416 - Pharmaceutical combination containing glucose kinase activator and PPAR receptor activator, composition, compound preparation method for same, and uses thereof (2024-08-20),

5. 11992477 - Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof (2024-05-28),

6. 11963947 - Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereof (2024-04-23),

7. 11666556 - Pharmaceutical combination, composition and compound preparation containing glucokinase activator and K-ATP channel blocker, preparation method therefor and use thereof (2023-06-06),

8. 11266630 - Oral preparation of glucokinase activator and preparation method therefor (2022-03-08),

9. 10669255 - Pyrrole derivatives (2020-06-02),

10. 8258149 - Isoquinoline derivatives (2012-09-04),

Title: Inventor Spotlight: Yongguo Li

Introduction

Yongguo Li, based in Shanghai, China, is a prominent inventor with a strong portfolio of seven patents. His innovative contributions primarily focus on pharmaceutical combinations that leverage advanced biochemical techniques to enhance therapeutic outcomes. Li's work reflects a commitment to addressing critical health challenges through inventive solutions.

Latest Patents

Yongguo Li's latest patents include two significant innovations in the field of pharmaceuticals. The first patent describes a pharmaceutical combination that contains a glucose kinase activator and a PPAR receptor activator. This invention not only emphasizes the combination of these compounds but also elaborates on the preparation methods and potential uses of the pharmaceutical composition.

The second patent involves a pharmaceutical combination that incorporates a glucokinase activator along with an SGLT-2 inhibitor. Similar to the first, this invention provides comprehensive details on the preparation methods, uses, and forms of the active ingredients, which includes potential isotopic labels and various structural forms of the compounds.

Career Highlights

Throughout his career, Yongguo Li has worked with reputable organizations, namely Hua Medicine (Shanghai) Ltd. and Hoffmann-La Roche Inc. His experience in these companies has undoubtedly shaped his expertise and knowledge in pharmaceutical innovations and research.

Collaborations

Li has collaborated with colleagues such as Li Chen and Gaosen Wang. These collaborations have played a significant role in driving forward innovative research and the development of new pharmaceutical solutions, expanding the boundaries of their field.

Conclusion

Yongguo Li exemplifies the spirit of innovation in pharmaceutical sciences. With a substantial number of patents to his name and a solid professional history, he continues to contribute valuable advancements in the industry. His work not only reflects his personal expertise but also enhances collective efforts in improving health outcomes through scientific discovery.